Abstract
Gene therapy has drawn significant attention as a potential method for treating both acute illnesses and chronic diseases. Current research efforts have focused on developing carriers that effectively compact and protect naked DNA, RNA and siRNA, which are rapidly degraded by enzymes in the blood. As an alternative to viral and polymeric carriers, nanoparticles have been introduced as promising carriers with low toxicity profiles and well-controlled gene delivery efficiency. While significant advances have been made for in vitro applications, much still remains to be done, especially for in vivo translation. Here we provide a concise review on the development of nanoparticles for gene delivery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
